Pernix Therapeutics (PTX) to Acquire Zogenix's (ZGNX) Zohydro ER Business
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/25/2024
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Hasbro (HAS) brand strength sees earnings top expectations
- Meta Platforms (META) Tops Q1 EPS by 39c, Offers Guidance
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Rubrik (RBRK) Prices Upsized 23.5M Share IPO at $32/sh
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
Cantor Fitzgerald Downgrades Pernix Therapeutics (PTX) to Hold on Zohydro Deal
March 12, 2015 6:52 AM EDTCantor Fitzgerald downgraded Pernix Therapeutics (NASDAQ: PTX) from Buy to Hold with a price target of $11.00 (from $12.00) as they take a "wait and see" approach to Pernix's aggressive transformational pain deal.
Irina Rivkind Koffler said, "We model 33% EPS dilution in 2015 (but +16% accretion in... More
William Blair Downgrades Zogenix, Inc. (ZGNX) to Market Perform
March 11, 2015 7:08 AM EDTWilliam Blair downgraded Zogenix, Inc. (NASDAQ: ZGNX) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Zogenix, Inc. click here. For more ratings news on Zogenix, Inc. click here.
Shares of Zogenix, Inc. closed at $1.67 yesterday.
... MorePernix Therapeutics (PTX) Bullish Stance Reiterated at Needham & Company Following Zohydro ER Deal
March 11, 2015 6:42 AM EDTNeedham & Company analyst Elliot Wilbur reiterated a Strong Buy rating and $16 price target on Pernix Therapeutics (NASDAQ: PTX) after the company announced purchase of Zohydro ER.
Wilbur commented, "PTX is back in deal mode, announcing the purchase of Zohydro ER, a marketed long-acting abuse... More
